VIP in Thailand: Immune Modulation & Anti-Inflammatory Therapy
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide that modulates neuroinflammation, immune balance, and gut motility through widespread receptor distribution in the nervous and immune systems. In physician-supervised protocols, it is studied for autoimmune support, neuroinflammatory conditions, and chronic inflammatory disease management.
Doctor-prescribed VIP in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified sourcing. It is prescribed for neuroinflammatory and autoimmune support protocols, particularly for patients with inflammatory conditions affecting the nervous system, gut, or respiratory tract.
How VIP (Vasoactive Intestinal Peptide) Works
VIP operates through sophisticated pathways to regulate immune function and maintain physiological balance. Its primary mechanism involves binding to specific receptors (VPAC1 and VPAC2) that modulate immune responses and inflammatory processes. The peptide also influences neurotransmitter systems, affects smooth muscle function, and helps regulate circadian rhythms. Additionally, VIP demonstrates significant anti-inflammatory properties and supports cellular protection through multiple molecular pathways.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
VIP (Vasoactive Intestinal Peptide)
Category
Nasal Peptide
Dosage
50-100mcg per dose
Frequency
1-2 times daily
Administration
Subcutaneous injection or nasal spray
Potential Benefits
- · Regulates immune system response
- · Reduces chronic inflammation
- · Supports digestive system health
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
VIP (Vasoactive Intestinal Peptide) requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Regulates immune system response
Reduces chronic inflammation
Supports digestive system health
Improves circadian rhythm function
Shows neuroprotective effects
May help with autoimmune conditions
Supports respiratory health
Enhances cellular protection
Helps maintain gut barrier integrity
Demonstrates anti-inflammatory properties
Speak with a physician
Interested in VIP (Vasoactive Intestinal Peptide)?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
50-100mcg per dose
Frequency
1-2 times daily
Duration
8-12 weeks per cycle
Administration
Subcutaneous injection or nasal spray
Safety guide
VIP (Vasoactive Intestinal Peptide) Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent VIP (Vasoactive Intestinal Peptide) Research
VIP Exerts Therapeutic Action by Regulating PTEN in a Model of Sjogrens Disease
Demonstrated that VIP modulates PTEN signalling to exert immunomodulatory effects in Sjogren's disease, reducing glandular inflammation and autoimmune pathology (Immun Inflamm Dis, 2023).
View on PubMedVasoactive Intestinal Peptide Indirectly Elicits Pituitary LH Secretion Independent of GnRH
Showed VIP regulates hypothalamic-pituitary hormone release through indirect mechanisms, highlighting its broad role in neuroendocrine and reproductive physiology (Endocrinology, 2022).
View on PubMedMechanism of Immunoregulatory Properties of VIP in the K/BxN Mouse Model of Rheumatoid Arthritis
Demonstrated VIP reduces joint inflammation and autoimmune pathology in a rheumatoid arthritis model by shifting immune balance toward a regulatory phenotype (Front Immunol, 2021).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about VIP (Vasoactive Intestinal Peptide)